Gene fusion has been shown to play a key role in the development of blood cancers and common solid tumors such as prostate, lung, colon and breast cancer. As leaders in the discovery and development of the next generation of personalized therapeutics for cancer patients, our work is frequently published in scientific journals and spotlighted by national media.
We are also active in professional organizations, both as presenters and attendees at conferences and events. To view the upcoming events we will be attending or read the latest media coverage, please visit our News and Events page.
For media inquiries, please contact us.